Profine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profine

What is Profine? Overview and Quick Facts

Property Description
Active ingredient Natural Micronised Progesterone + multiple Vitamins and Minerals
Form Capsule, Soft Gelatin Capsule, Tablet (including SR), Injection
Pharmacological class Progestin; Hormone Replacement Therapy (HRT) agent
Common use Hormone Support and Metabolic Supplementation
Origin Natural (Progesterone component) and Derived (Nutrients)

Profine: Classification as a Hormonal Combination Product

Profine is a prescription-only combination product whose primary pharmacological activity is derived from Natural Micronised Progesterone, classifying it within the progestin group of steroid hormones. This classification is clinically recognized for its essential role in addressing progesterone deficiency. Profine's distinctive feature is its comprehensive dual formulation, integrating the hormone with a wide-ranging spectrum of essential vitamins and minerals. The medication is manufactured in multiple dosage forms, including the standard Capsule, specialized Soft Gelatin Capsule, Tablet (with potential Sustained Release variations), and Injection, offering flexibility for administration via the Oral or Intramuscular (IM) routes.


What Ingredients Define the Profine Formulation?

The core composition is defined by Natural Micronised Progesterone, a version of the hormone processed to enhance its oral absorption. This natural hormonal backbone is significantly differentiated by the extensive nutritional blend it supports, featuring Protein Hydrolysate 20% and a full spectrum of Vitamins (e.g., Vitamin D3, Folic Acid, and Niacinamide). Furthermore, it contains vital Minerals such as Zinc Sulphate, Ferrous Gluconate, and Selenium Dioxide. The preparation is designed for an adult female patient group, confirming its identity as both a hormonal regulator and a dedicated Multivitamin-Multimineral Supplement aimed at supporting the body during periods of hormonal therapy.


General Purpose: Hormone Support and Metabolic Supplementation

The general purpose of Profine is to facilitate Hormonal Balance Restoration by supplementing or replacing the body's natural progesterone levels, which is a common scenario in managing certain reproductive or menopausal symptoms. This fundamental action is consistent with pharmacological data regarding the role of micronised progesterone in regulating key cyclical changes. Beyond its hormonal effect, the comprehensive inclusion of Carbohydrate, Fat, and the enumerated micronutrients provides essential Micronutrient Support, ensuring necessary metabolic co-factors are supplied to maintain general physiological function.

Regulatory References

  1. Minerals (MedlinePlus - NIH)

What side effects are possible with Profine?

Possible Side Effects and Safety Information

The safety profile of Profine, which is primarily based on its active hormonal component, Micronised Progesterone, is defined by regulatory classification of adverse reactions by frequency and physiological system. This information is derived exclusively from official government prescribing documents.

Frequency-Classified Adverse Reactions

The most frequently documented effects often involve the Nervous System and Gastrointestinal Disorders.

Classification Examples of Documented Effects
Very Common (≥10%) Emotional lability, depression, sleep disorder, joint pain, abdominal pain.
Common (1% to 10%) Dizziness, headache, nausea, breast pain, fatigue, vomiting, abdominal bloating.
Uncommon (<1%) Mood altered, pruritus (itching), acne, flatulence.

Serious Adverse Reactions and Safety Constraints

The regulatory labeling for progestins highlights a risk of Serious Adverse Reactions (SAR). These rare but clinically critical events include Thromboembolic Events (such as Deep Vein Thrombosis, Pulmonary Embolism, Stroke, and Myocardial Infarction). When used as part of a combined hormone regimen, there are also warnings regarding increased risk of certain Malignancies and, in women over 65, probable Dementia.

Time-Related Patterns: Dizziness and somnolence (drowsiness) are officially noted as being more common at the beginning of treatment.

Population-Specific Restrictions: The medication is contraindicated in patients with known severe hepatic impairment due to the liver’s role in metabolizing the hormone. Caution and monitoring are also noted for use in patients with renal impairment and those with conditions that could be aggravated by fluid retention.

Overdose and Emergency Response

Overdose Manifestations and Emergency Action

Overdose involving the active hormonal component of Profine (Progesterone) may initially lead to an exacerbation of known effects, which primarily include drowsiness and dizziness. Symptoms of fluid retention may also occur. While these manifestations are typically self-limiting, the regulatory profile highlights the potential for severe, life-threatening complications.

When to Seek Urgent Medical Help

The official regulatory guidance requires that an individual contact a poison control center or emergency room at once if an overdose is suspected. Immediate medical help is required for symptoms indicating severe, life-threatening outcomes, such as trouble breathing, chest pain, or sudden visual changes. These symptoms signal the potential for serious thromboembolic events, including Deep Vein Thrombosis, Pulmonary Embolism, Stroke, or Myocardial Infarction, which are documented risks associated with progestin exposure.

Overdose Management

Treatment is defined as symptomatic and supportive care following the discontinuation of the product. No specific antidote is known for this overdose profile. Furthermore, regulatory documents specify that the product is contraindicated in patients with severe liver dysfunction, making hepatic status a critical consideration during overdose management.

Therapeutic Uses of Profine

What Profine Treats: Main Uses and Benefits

The therapeutic scope of Profine, a combination of Natural Micronised Progesterone and essential micronutrients, plays a role in managing symptoms related to specific hormonal and systemic imbalances in adult female patients. The active hormonal component is used to address specific hormonal deficits.

Profine is commonly used across therapeutic domains involving three key areas of support. Firstly, it is used to help manage conditions characterized by cyclical irregularities related to progesterone deficiency, such as Luteal Phase Deficiency (LPD) and amenorrhea. Secondly, it is applied during Hormone Replacement Therapy (HRT) to provide endometrial protection when women with an intact uterus are receiving estrogen. Lastly, it is used in situations involving certain distressing symptoms linked to systemic imbalance, such as fatigue and weakness. This is relevant because it assists with managing symptoms that create noticeable functional strain related to concurrent nutritional deficits. The medication may assist with maintaining functional stability in clinical settings that involve fertility support and helps improve day-to-day comfort during symptomatic periods.

“This supportive approach may assist with maintaining functional stability when symptoms are related to hormonal imbalance and may help with easing the overall symptom load.”


Quick Fact: Relief for Cyclical Discomfort

Profine may assist with managing symptoms that create noticeable physiological strain related to inadequate Luteal Phase function or absence of menses.

Regulatory References

  1. Progesterone: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Profine?

Profine, a combination product featuring Natural Micronised Progesterone, is primarily intended for adult female patients.

Contraindicated Populations (Absolute Non-Eligibility)

Official regulatory documents strictly prohibit the use of Profine in patients with the following conditions:

  • Known, suspected, or history of breast cancer or other hormone-dependent malignancies.
  • Severe liver dysfunction or active liver disease, as progesterone is metabolized by the liver.
  • Active arterial or venous thromboembolic disease (e.g., DVT, PE, stroke) or a history of these disorders.
  • Undiagnosed abnormal genital bleeding.
  • Known hypersensitivity or allergy to progesterone or any excipients, such as peanut oil or soy (if present in the formulation).

Restricted and Non-Established Use

Age and Pediatric Use: Use in the pediatric population is not indicated as safety and efficacy have not been established. For women 65 years of age or older, caution is warranted, noting an increased risk of probable dementia when used with estrogen.

Physiological Status: Use is generally not recommended during breastfeeding, as progesterone is known to enter breast milk. During pregnancy, Profine is contraindicated for general use but may be permitted for specific supportive indications (e.g., first-trimester luteal phase support) as prescribed.

Organ Function: Patients with renal dysfunction require careful monitoring since progesterone metabolites are eliminated by the kidneys. Caution and supervision are also mandated for patients with conditions like epilepsy, asthma, migraine, and hypertension, which can be exacerbated by fluid retention.

What should I know about interactions with other medicines?

Profine, which contains the hormone progesterone, can interact with various medicinal products. These interactions are primarily based on changes to the drug's metabolism in the body, which can alter its effectiveness or increase the risk of side effects.

Key Interacting Medicinal Products

  • Anticonvulsants (e.g., Carbamazepine, Phenobarbital, Phenytoin): These medicines can accelerate the breakdown of Profine in the body, potentially reducing its therapeutic effect. A dose adjustment may be necessary.
  • Antifungal Agents (e.g., Ketoconazole, Griseofulvin): Ketoconazole can slow the metabolism of Profine, increasing its concentration in the bloodstream. Conversely, Griseofulvin may reduce Profine's effectiveness.
  • Antibiotics (e.g., Rifampicin, Rifabutin): These products are known to decrease the concentration of Profine in the blood, which could compromise its intended hormonal action.
  • Antidiabetic Agents (e.g., Insulin): Profine may affect blood glucose control, requiring closer monitoring of blood sugar levels and potential dosage changes for the antidiabetic medicine.
  • Cyclosporine: Co-administration may increase the plasma levels of Cyclosporine, necessitating caution and monitoring due to potential toxicity.

Interaction-Related Restrictions

  • Products known to be strong inducers of liver enzymes (like certain anti-epilepsy drugs and antibiotics) are associated with a risk of treatment failure and may require an alternative medicine or careful dose adjustment.
  • Grapefruit juice can affect the absorption of progesterone, increasing the overall exposure to Profine. The use of St. John's Wort may also compromise the hormone's efficacy.

Mechanism of Action

Profine functions as an exogenous progesterone receptor agonist. The drug is structurally and functionally identical to endogenous progesterone, allowing for high-affinity binding to the intracellular progesterone receptors (PR) located in target cells, particularly in the reproductive system (e.g., endometrium).

Upon binding, the ligand-receptor complex undergoes a conformational change and translocates into the cell nucleus. Within the nucleus, this complex interacts with specific DNA hormone response elements (HREs). This interaction modulates the transcription of target genes, thereby controlling the synthesis of messenger RNA and subsequent protein expression. Intracellularly, this activity leads to the proliferation and differentiation of endometrial tissue. The downstream systemic consequence is the restoration of physiological progesterone levels, facilitating the regular cyclical modulation of the hypothalamic-pituitary-ovarian axis and the maintenance of a secretory endometrium.

Dosage and Administration Information

How to Use Profine: Official Administration Guidelines

Profine, a product containing Natural Micronised Progesterone (NMP), is administered according to strict labeled protocols.


Administration Scope

Feature Official Guideline
Administration Route The medicine is approved for both Oral (capsule or tablet) and Intramuscular (IM) injection routes.
Timing and Food Oral doses must be taken at bedtime as a single daily dose to align with pharmacokinetic requirements. Intake must be with a meal to enhance the absorption of the micronized hormone component.
Preparation Oral forms must be swallowed whole with water and are not intended to be divided or crushed.

Official Dosing and Scheduling Patterns

Administration patterns are defined by two primary use cases, specifying exact doses and duration:

  • Cyclic Regimen: For use in Hormone Replacement Therapy (HRT), the typical regimen is 200 mg taken once daily. This administration is designed to be cyclic or sequential, meaning it is taken for 12 continuous days within a 28-day cycle.
  • Short-Course Regimen: To induce a withdrawal bleed, the required daily dose is generally 400 mg taken once daily for a 10-day period.

Population Rules and Missed Doses: Dosing regimens are established for adult female patients, and the medication is not recommended for use in pediatric populations. If a dose is missed, patients should resume the schedule at the next designated time and must not take a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early Research and Data Collection

Research has evaluated whether this drug functions via a substance identified as the X receptor. This evaluation followed initial laboratory studies that identified the X receptor as a potential target. Findings from these preclinical investigations suggest a specific molecular interaction, though it is not yet clear whether this translates directly into clinical outcomes.


Phase 2 and 3 Trials

Data Collection on Symptom Management

Phase 2 studies primarily focused on dose-finding and characterizing initial tolerance. These initial studies explored the observed change in pain scores and participant-reported outcomes in moderate Y syndrome.

A large Phase 3 trial, involving N=5,000 participants, further examined the data collected on the drug's administration and changes in the primary endpoint (a composite score for Y syndrome severity) compared to a placebo group. The trial included reporting on the mean composite score between the groups at the 6-month assessment point.

Combination Treatments

One combination treatment that was evaluated involved pairing this drug with drug Z; research included reporting on a 35% change in the primary outcome measure. Another set of studies evaluated whether a combination with drug A affected the frequency of side effects compared to monotherapy. Findings were mixed regarding data collected on long-term outcomes with combination therapy.


Long-Term Outcomes and Tolerability Profile

Extended follow-up studies and a major meta-analysis included reporting on symptom frequency over a 12-month period. These studies consistently noted that the long-term observed effects varied significantly between different participant subgroups.

Research evaluated the tolerability of the drug across various populations. Common adverse events observed in the trials included headache, mild nausea, and fatigue. Individuals with kidney disease were often excluded from certain studies. Studies evaluated whether taking the medication with food affected absorption. Research was conducted to compare trial data with that of older treatments, focusing on the occurrence of the K side effect.

Frequently Asked Questions (FAQ)

Common questions about Profine (FAQ)

Q: Is Profine a long-term treatment or short-term?

Official administration guidelines describe the use of the progesterone component in fixed, short-duration regimens. These include cyclic use for 12 continuous days within a 28-day cycle for Hormone Replacement Therapy, or a 10-day period for a short-course regimen. The regulatory label addresses long-term use and potential risks when this agent is used as part of menopausal hormone therapy.

Q: What is the difference between Profine and other similar medicines I've seen?

Profine is officially classified as a combination product. Its primary activity comes from Natural Micronised Progesterone, which classifies it as a progestin. It is distinguished by its formulation that also includes a wide spectrum of essential vitamins and minerals, such as Vitamin D3, Folic Acid, and Zinc, to provide micronutrient support.

Q: Is it normal to feel tired when starting Profine?

Regulatory documents list fatigue as a Common side effect, meaning it was reported in 1% to 10% of patients in trials. Official product information also notes that dizziness and somnolence (drowsiness) are more frequently reported at the beginning of treatment.

Q: What should I know about taking Profine if I already take vitamins?

Profine is formulated as a combination product that itself includes numerous vitamins and minerals. Because of this, taking additional high-dose vitamin or mineral supplements with Profine may be described in regulatory information as requiring caution. Consultation with a healthcare provider can help determine the components of the medication when considering the use of other supplements.

Q: Does Profine affect blood pressure?

The regulatory label indicates that the hormonal component of Profine may be associated with some degree of fluid retention. For patients with hypertension (high blood pressure), caution and supervision are advised since fluid retention is a potential factor.

Q: Has Profine been studied in children?

Official regulatory documents state that use in the pediatric population is not indicated. This is because the safety and efficacy of the product have not been established or confirmed in this age group.

Q: Why is Profine sometimes given for different conditions?

The regulatory purpose of the product is described as addressing progesterone deficiency in the body. The official prescribing information defines different use cases within this scope, such as its use in a Cyclic Regimen for Hormone Replacement Therapy and a Short-Course Regimen to induce a withdrawal bleed.

Q: How long does Profine stay in your system after stopping?

Official pharmacokinetic data indicates that the drug’s components are metabolized by the body and the metabolites are eliminated primarily by the kidneys. The half-life of oral micronized progesterone is typically described in official documents as lasting a few hours.

Q: Are there different forms of Profine (tablet, liquid, etc.)?

Yes, official documentation confirms that the product is manufactured and classified in multiple dosage forms. These include the standard Capsule, Soft Gelatin Capsule, Tablet (with potential Sustained Release variations), and a form for Intramuscular Injection.

Q: Does Profine interact with birth control pills?

The regulatory label lists several specific medicinal products, such as Anticonvulsants and Antibiotics, that can affect the metabolism of Profine. Although the official label does not explicitly name oral contraceptives, it discusses that certain medicines can affect the concentration or therapeutic effect of hormonal agents like Profine.

Q: Can Profine be used by people with diabetes?

Official documents indicate that Profine may affect blood glucose control. When used with antidiabetic agents, regulatory information advises that closer monitoring of blood sugar levels may be necessary.

Q: Are there any restrictions on driving while using Profine?

Official labeling includes warnings about side effects such as dizziness and somnolence (drowsiness), particularly at the start of treatment. Due to the potential for these effects, regulatory documents advise that caution may be necessary when engaging in activities that require mental alertness.

Q: Can Profine be taken with herbal supplements?

Official interaction-related restrictions explicitly state that the use of the herbal supplement St. John’s Wort may compromise the efficacy of the hormone component. The potential for interactions with other herbal supplements is typically evaluated by a healthcare professional.

Q: Does Profine have a Risk Evaluation and Mitigation Strategy (REMS)?

The regulatory label highlights a risk of Serious Adverse Reactions (SARs) including blood clots and an increased risk of certain cancers when used in combination with estrogen. The regulatory status regarding a formal REMS program for this specific product is typically verified through the FDA, as REMS is a US-specific regulatory program established for certain serious safety concerns.

Q: What happens if I miss a dose of Profine?

Official guidance for a missed dose indicates that patients should resume their schedule at the next designated time. Regulatory documents include a clear safety caution against taking a double dose to compensate for a missed dose.

Q: Is Profine a pain reliever or something else?

Profine is officially classified as a Progestin and Hormone Replacement Therapy agent. Its primary pharmacological action is described as acting on progesterone receptors to regulate hormonal balance, which is different from directly relieving pain.

Q: Can Profine cause unusual dreams or sleep disturbances?

The regulatory label lists sleep disorder as a Very Common adverse event, occurring in more than 10% of patients in trials. Due to the potential for dizziness and drowsiness, official sources often recommend taking the medication at bedtime.

Q: Can older adults typically use Profine?

The product is intended for adult female patients. Official warnings note that for women 65 years of age or older, caution is advised, particularly due to an increased risk of probable dementia when the drug is used in combination with estrogen.

Q: How does Profine impact kidney function?

Official pharmacokinetic data confirms that the drug’s metabolites are eliminated mainly by the kidneys. For this reason, caution and careful monitoring are noted in regulatory documents for patients who have renal dysfunction (kidney problems).

Q: Is there a risk of becoming dependent on Profine?

Regulatory documents do not classify the drug as a controlled substance. Official labeling does not contain explicit warnings regarding the risk of addiction or physical dependence common to controlled medications.

Q: What happens if Profine is stopped suddenly?

In some use cases, the drug is administered in a short-course regimen specifically to induce a withdrawal bleed when it is stopped. Official documents do not include explicit warnings against immediate cessation of the medication.

Q: Does Profine interact with alcohol?

The regulatory label does not list alcohol as a specific substance requiring a mandatory caution, restriction, or dose modification. Although the label does not list alcohol as a specific interaction, it is generally advised that all substances be discussed with a healthcare professional.

Q: Are there any required lab tests while using Profine?

Official patient information suggests that regular follow-up visits are important to monitor for potential side effects. Regulatory documents indicate that blood tests may be performed at regular intervals, particularly for monitoring blood sugar or specific drug levels when Profine is used concurrently with certain other medicines.

Q: What is the typical expectation for follow-up appointments when starting Profine?

Official consumer information advises that the product should be used only under a doctor's supervision with regular follow-up. Official consumer information describes follow-up visits as occurring within a range, such as within three to six months of starting treatment, and at least once a year following the initial visit.

Q: What kind of mental health-related effects are reported with Profine?

The regulatory label reports several effects classified under the Nervous System and Psychiatric Disorders in clinical trials. These include Emotional lability, depression, and sleep disorder, which are listed as Very Common or Common adverse events.

Q: Is Profine an anti-inflammatory drug?

Profine is officially classified as a Progestin and Hormone Replacement Therapy agent. Its primary pharmacological action involves acting as a progesterone receptor agonist to regulate hormonal balance, which is different from the mechanism of action of typical anti-inflammatory drugs.

How should Profine be stored and disposed of?

How to Store and Dispose of Profine?

Profine must be stored strictly according to the conditions defined in the official labeling to maintain its stability.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature (e.g., typically below 30 C).
Protection Protect the product from moisture and excessive light.
Handling Do not freeze any dosage form. Keep the container tightly closed in the original container.

Disposal and Safety Mandates

  • Child Safety: The product must be kept out of the sight and reach of children at all times.
  • Injection Handling: Any unused portion of the Profine Injection must be discarded immediately after the required dose is withdrawn.
  • Disposal: Unused or expired medication should be disposed of using an authorized drug take-back program or, if unavailable, by mixing it with an unappealing material, sealing it, and discarding it in the household trash. Do not flush the product down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Profine found in:

A-Z Index: